drug

daxdilimab

1 story · latest Aug 28, 2026

Status: Investigational
Code: HZN-7734
Trials: 1 registered trial in coverage

Relationships

Developed by Amgen

Timeline

Amgen posts results for rocatinlimab AD trial, daxdilimab myositis study; mCRPC trial terminated

Aug 28Weekly roundup, 3 itemsacapatamab Amgen

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.